Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.
2.

Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives.

Ziegler AG, Danne T, Dunger DB, Berner R, Puff R, Kiess W, Agiostratidou G, Todd JA, Bonifacio E.

Mol Metab. 2016 Feb 22;5(4):255-262. doi: 10.1016/j.molmet.2016.02.003. eCollection 2016 Apr. Review.

3.

N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.

Qian X, Anzovino A, Kim S, Suyama K, Yao J, Hulit J, Agiostratidou G, Chandiramani N, McDaid HM, Nagi C, Cohen HW, Phillips GR, Norton L, Hazan RB.

Oncogene. 2014 Jun 26;33(26):3411-21. doi: 10.1038/onc.2013.310. Epub 2013 Aug 26.

4.

Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options.

Elefteriou F, Kolanczyk M, Schindeler A, Viskochil DH, Hock JM, Schorry EK, Crawford AH, Friedman JM, Little D, Peltonen J, Carey JC, Feldman D, Yu X, Armstrong L, Birch P, Kendler DL, Mundlos S, Yang FC, Agiostratidou G, Hunter-Schaedle K, Stevenson DA.

Am J Med Genet A. 2009 Oct;149A(10):2327-38. doi: 10.1002/ajmg.a.33045. Review.

PMID:
19764036
5.

Loss of retinal cadherin facilitates mammary tumor progression and metastasis.

Agiostratidou G, Li M, Suyama K, Badano I, Keren R, Chung S, Anzovino A, Hulit J, Qian B, Bouzahzah B, Eugenin E, Loudig O, Phillips GR, Locker J, Hazan RB.

Cancer Res. 2009 Jun 15;69(12):5030-8. doi: 10.1158/0008-5472.CAN-08-4007. Epub 2009 Jun 2.

6.

Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.

Agiostratidou G, Hulit J, Phillips GR, Hazan RB.

J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):127-33. Review.

PMID:
17564818
7.

N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.

Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB.

Cancer Res. 2007 Apr 1;67(7):3106-16.

8.

The cytoplasmic sequence of E-cadherin promotes non-amyloidogenic degradation of A beta precursors.

Agiostratidou G, Muros RM, Shioi J, Marambaud P, Robakis NK.

J Neurochem. 2006 Feb;96(4):1182-8. Epub 2006 Jan 26.

9.

Differential effects of clusterin/apolipoprotein J on cellular growth and survival.

Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES.

Free Radic Biol Med. 2005 Feb 15;38(4):436-49.

PMID:
15649646
10.
11.

Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients.

Agiostratidou G, Sgouros I, Galani E, Voulgari A, Chondrogianni N, Samantas E, Dimopoulos MA, Skarlos D, Gonos ES.

Anticancer Res. 2001 Jan-Feb;21(1A):455-9.

PMID:
11299779
12.

Evaluation of cytotoxic treatment of patients with osteosarcoma by an in vitro chemoresistance assay.

Agiostratidou G, Demertzis N, Gonos ES.

Anticancer Res. 2000 Sep- Oct;20(5B):3603-8.

PMID:
11131668
13.

Aging and longevity. A paradigm of complementation between homeostatic mechanisms and genetic control?

Petropoulou C, Chondrogianni N, Simões D, Agiostratidou G, Drosopoulos N, Kotsota V, Gonos ES.

Ann N Y Acad Sci. 2000 Jun;908:133-42. Review.

PMID:
10911954
14.

Cloning and identification of genes that associate with mammalian replicative senescence.

Gonos ES, Derventzi A, Kveiborg M, Agiostratidou G, Kassem M, Clark BF, Jat PS, Rattan SI.

Exp Cell Res. 1998 Apr 10;240(1):66-74.

PMID:
9570922
15.

Supplemental Content

Loading ...
Support Center